Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data

[1]  E. Banks,et al.  Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study. , 2015, Vaccine.

[2]  Paul Badcock,et al.  Knowledge about and experience of sexually transmissible infections in a representative sample of adults: the Second Australian Study of Health and Relationships. , 2014, Sexual health.

[3]  J. Brotherton,et al.  Assessing HPV vaccine coverage in Australia by geography and socioeconomic status: are we protecting those most at risk? , 2014, Australian and New Zealand journal of public health.

[4]  Deborah Bateson,et al.  Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. , 2014, The Lancet. Infectious diseases.

[5]  M. Hickman,et al.  Examining inequalities in the uptake of the school-based HPV vaccination programme in England: a retrospective cohort study. , 2014, Journal of public health.

[6]  Basil Donovan,et al.  Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey. , 2014, Vaccine.

[7]  D. Mesher,et al.  Coverage of the English national human papillomavirus (HPV) immunisation programme among 12 to 17 year-old females by area-level deprivation score, England, 2008 to 2011. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[8]  J. Seidel,et al.  Social equity in Human Papillomavirus vaccination: a natural experiment in Calgary Canada , 2013, BMC Public Health.

[9]  J. Hadler,et al.  Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008–2011 , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[10]  J. Brotherton,et al.  Human papillomavirus vaccination and cervical cancer screening by socioeconomic status, Victoria , 2012, The Medical journal of Australia.

[11]  A. Giuliano,et al.  Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. , 2011, The Journal of infectious diseases.

[12]  D. Whynes,et al.  Explaining variation in the uptake of HPV vaccination in England , 2011, BMC public health.

[13]  J. Palefsky,et al.  Human papillomavirus-related disease in men: not just a women's issue. , 2010, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[14]  R. Railkar,et al.  Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. , 2009, The Journal of infectious diseases.

[15]  J. Brotherton.  How much cervical cancer in Australia is vaccine preventable? A meta-analysis. , 2008, Vaccine.

[16]  Bruce K Armstrong,et al.  Remoteness of residence and survival from cancer in New South Wales , 2004, The Medical journal of Australia.

[17]  B. Chait,et al.  Supervillin binding to myosin II and synergism with anillin are required for cytokinesis , 1992, Molecular biology of the cell.

[18]  Bette C Liu,et al.  Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data. , 2015, The Journal of infectious diseases.

[19]  C. Andrzejewski,et al.  BMC Infectious Diseases , 2006 .